Literature DB >> 17027094

Neuroprotection by endogenous and exogenous PACAP following stroke.

Yun Chen1, Babru Samal, Carol R Hamelink, Charlie C Xiang, Yong Chen, Mei Chen, David Vaudry, Michael J Brownstein, John M Hallenbeck, Lee E Eiden.   

Abstract

We investigated the effects of PACAP treatment, and endogenous PACAP deficiency, on infarct volume, neurological function, and the cerebrocortical transcriptional response in a mouse model of stroke, middle cerebral artery occlusion (MCAO). PACAP-38 administered i.v. or i.c.v. 1 h after MCAO significantly reduced infarct volume, and ameliorated functional motor deficits measured 24 h later in wild-type mice. Infarct volumes and neurological deficits (walking faults) were both greater in PACAP-deficient than in wild-type mice, but treatment with PACAP reduced lesion volume and neurological deficits in PACAP-deficient mice to the same level of improvement as in wild-type mice. A 35,546-clone mouse cDNA microarray was used to investigate cortical transcriptional changes associated with cerebral ischemia in wild-type and PACAP-deficient mice, and with PACAP treatment after MCAO in wild-type mice. 229 known (named) transcripts were increased (228) or decreased (1) in abundance at least 50% following cerebral ischemia in wild-type mice. 49 transcripts were significantly up-regulated only at 1 h post-MCAO (acute response transcripts), 142 were up-regulated only at 24 h post-MCAO (delayed response transcripts) and 37 transcripts were up-regulated at both times (sustained response transcripts). More than half of these are transcripts not previously reported to be altered in ischemia. A larger percentage of genes up-regulated at 24 hr than at 1 hr required endogenous PACAP, suggesting a more prominent role for PACAP in later response to injury than in the initial response. This is consistent with a neuroprotective role for PACAP in late response to injury, i.e., even when administered 1 hr or more after MCAO. Putative injury effector transcripts regulated by PACAP include beta-actin, midline 2, and metallothionein 1. Potential neuroprotective transcripts include several demonstrated to be PACAP-regulated in other contexts. Prominent among these were transcripts encoding the PACAP-regulated gene Ier3, and the neuropeptides enkephalin, substance P (tachykinin 1), and neurotensin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027094      PMCID: PMC4183206          DOI: 10.1016/j.regpep.2006.06.016

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  76 in total

1.  Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.

Authors:  D Reglodi; A Somogyvari-Vigh; S Vigh; T Kozicz; A Arimura
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke.

Authors:  A Rawanduzy; A Hansen; T W Hansen; M Nedergaard
Journal:  J Neurosurg       Date:  1997-12       Impact factor: 5.115

3.  A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.

Authors:  Russell P Bowler; Huaxin Sheng; Jan J Enghild; Robert D Pearlstein; David S Warner; James D Crapo
Journal:  Free Radic Biol Med       Date:  2002-10-15       Impact factor: 7.376

4.  Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity.

Authors:  H Morio; I Tatsuno; A Hirai; Y Tamura; Y Saito
Journal:  Brain Res       Date:  1996-11-25       Impact factor: 3.252

5.  Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.

Authors:  N Takei; Y Skoglösa; D Lindholm
Journal:  J Neurosci Res       Date:  1998-12-01       Impact factor: 4.164

6.  Involvement of endogenous PACAP expression in the activity-dependent survival of mouse cerebellar granule cells.

Authors:  A Tabuchi; M Koizumi; J Nakatsubo; T Yaguchi; M Tsuda
Journal:  Neurosci Res       Date:  2001-01       Impact factor: 3.304

Review 7.  [Prevention of delayed neuronal cell death by PACAP and its molecular mechanism].

Authors:  Seiji Shioda; Hirokazu Ohtaki; Ryusuke Suzuki; Tomoya Nakamachi; Fumiko Takenoya; Kenji Dohi; Shigeo Nakajo
Journal:  Nihon Yakurigaku Zasshi       Date:  2004-04

8.  L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.

Authors:  E Morikawa; M A Moskowitz; Z Huang; T Yoshida; K Irikura; T Dalkara
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

9.  Neurochemical changes following occlusion of the middle cerebral artery in rats.

Authors:  G V Allen; R T Cheung; D F Cechetto
Journal:  Neuroscience       Date:  1995-10       Impact factor: 3.590

10.  BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.

Authors:  M J Leach; J H Swan; D Eisenthal; M Dopson; M Nobbs
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

View more
  54 in total

1.  Acute Response of the Hippocampal Transcriptome Following Mild Traumatic Brain Injury After Controlled Cortical Impact in the Rat.

Authors:  Babru B Samal; Cameron K Waites; Camila Almeida-Suhett; Zheng Li; Ann M Marini; Nihar R Samal; Abdel Elkahloun; Maria F M Braga; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2015-08-29       Impact factor: 3.444

2.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

3.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

5.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

6.  Biological and structural analysis of truncated analogs of PACAP27.

Authors:  Steve Bourgault; David Vaudry; Laure Guilhaudis; Emilie Raoult; Alain Couvineau; Marc Laburthe; Isabelle Ségalas-Milazzo; Hubert Vaudry; Alain Fournier
Journal:  J Mol Neurosci       Date:  2008-05-13       Impact factor: 3.444

7.  Comparison of intestinal warm ischemic injury in PACAP knockout and wild-type mice.

Authors:  Andrea Ferencz; Peter Kiss; Gyorgy Weber; Zsuzsanna Helyes; Norihito Shintani; Akemichi Baba; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-04-13       Impact factor: 3.444

8.  Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.

Authors:  Lee E Eiden; Babru Samal; Matthew J Gerdin; Tomris Mustafa; David Vaudry; Nikolas Stroth
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome.

Authors:  Ashuthosh Dharap; Kellie Bowen; Robert Place; Long-Cheng Li; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2009-01-14       Impact factor: 6.200

10.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.